1283.8000 6.90 (0.54%)
NSE Mar 17, 2026 15:59 PM
Volume: 1.0M
 

ICICI Direct
About the stock: Dr Reddy's (DRL) business encompasses generic formulations sales across US, Europe, RoW markets and branded generics in India and Russia CIS. The business also comprises of API sales under the head PSAI. The company...
Dr. Reddy's Laboratories Ltd. is trading above all available SMAs
More from Dr. Reddy's Laboratories Ltd.
Recommended